Metraipolis › archive › dc_4950660b74db
Polyclonal Antibody Therapeutics: Analytical Innovations and Regulatory Perspectives for Addressing Heterogeneity Challenges — Europe PMC PMID:41712472
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41712472
- DOI
- 10.1021/acs.analchem.5c06531
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T15:09:04.053Z
- SHA-256 of the archived text
7a146e4c57d46ab01bf5b9ffa9b3e4eaffba910a301abeb1c102e293ce47cb49- Stable URL of this page
https://metraipolis.com/documento/dc_4950660b74db
How to cite
Polyclonal Antibody Therapeutics: Analytical Innovations and Regulatory Perspectives for Addressing Heterogeneity Challenges — Europe PMC PMID:41712472 — Europe PMC (en), https://europepmc.org/article/MED/41712472 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4950660b74db (Metraipolis archive dc_4950660b74db, sha256 7a146e4c57d46ab01bf5b9ffa9b3e4eaffba910a301abeb1c102e293ce47cb49)
BibTeX
@misc{dc4950660b74db,
title = {Polyclonal Antibody Therapeutics: Analytical Innovations and Regulatory Perspectives for Addressing Heterogeneity Challenges — Europe PMC PMID:41712472},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41712472},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4950660b74db; sha256 7a146e4c57d46ab01bf5b9ffa9b3e4eaffba910a301abeb1c102e293ce47cb49},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41712472. Agents can read the archived copy with the MCP tool read_document.